JohnM.C. Connell is an author at Pfizer (United Kingdom) specializing in molecular pharmacology, drug discovery, and oxidative stress.
Top concepts
MedicineBiochemistryPharmacologyDrug DiscoveryPharmacotherapyOxidative StressMolecular Pharmacology
Publications per year
1989–1989
1
1
EFFECTS OF UK 69 578: A NOVEL ATRIOPEPTIDASE INHIBITOR
DavidB. Northridge, C T Alabaster, JohnM.C. Connell et al. · The Lancet · 1989 · 193 citations
Rows per page
1–1 of 1